Neoplasia — MCQs

A child is born with a single functional copy of a tumor suppressor gene. At the age of 5 years, the remaining normal allele is lost through mutation. As a result, the ability to control the transition from G1 to the S phase of the cell cycle is lost. Which of the following neoplasms is most likely to arise by means of this mechanism?

Q426Medium

Which of the following mutations is NOT involved in tobacco-induced squamous cell carcinoma?

Q427Easy

Which of the following is a marker for carcinoma of the colon?

Q428Easy

What is the most definite feature of a malignant tumour?

Q429Medium

A 51-year-old male with a 20-year history of tobacco chewing presents with a slowly enlarging, white, irregular mass on the floor of his mouth, measuring 1.3 cm. Biopsies of this lesion are most likely to reveal which malignancy?

Q430Easy

A metastatic carcinoma in the brain of an adult most often originates from a primary tumor in which of the following locations?

Neoplasia Indian Medical PG Practice Questions and MCQs

Question 421: Squamous cell carcinoma arises from which cell type?

A. Intercalated duct reserve cell.
B. Excretory duct reserve cell. (Correct Answer)
C. Both intercalated and excretory duct reserve cells.
D. None of the above.

Explanation: ### Explanation The histogenesis of salivary gland tumors is best explained by the **Bicellular Theory**, which suggests that all salivary neoplasms arise from two types of "reserve" (stem) cells: the intercalated duct reserve cell and the excretory duct reserve cell. **1. Why Option B is Correct:** The **Excretory duct reserve cells** are located in the large, distal ducts of the salivary glands. These cells are multipotent and are the precursors for the stratified squamous and columnar epithelium of the excretory ducts. Consequently, malignancies characterized by squamous differentiation—specifically **Squamous Cell Carcinoma (SCC)** and **Mucoepidermoid Carcinoma**—originate from these cells. **2. Why the Other Options are Incorrect:** * **Option A:** **Intercalated duct reserve cells** are located in the proximal portion of the ductal system. These cells give rise to the acini, intercalated ducts, and myoepithelial cells. Tumors arising from this lineage include **Pleomorphic Adenoma, Adenoid Cystic Carcinoma, and Acinic Cell Carcinoma.** * **Option C:** While both cells contribute to the spectrum of salivary tumors, they have distinct "zones of origin." SCC is restricted to the excretory duct lineage. **Clinical Pearls for NEET-PG:** * **Most common benign salivary tumor:** Pleomorphic Adenoma (arises from intercalated duct/myoepithelial cells). * **Most common malignant salivary tumor:** Mucoepidermoid Carcinoma (arises from excretory duct cells). * **Primary SCC of the salivary gland** is rare and must be differentiated from metastatic SCC (usually from the skin or oropharynx) or the squamous component of a Mucoepidermoid Carcinoma. * **Warthin’s Tumor** is unique as it is thought to arise from heterotopic salivary gland tissue trapped within intra-parotid lymph nodes.

Question 422: What causes the appearance of mammary skin described as "peau d'orange"?

A. Intraepithelial carcinoma
B. Subepidermal carcinoma
C. Lymphatic invasion (Correct Answer)
D. Vascular embolization

Explanation: **Explanation:** **Peau d’orange** (French for "orange peel skin") is a classic clinical sign of inflammatory breast cancer or advanced underlying malignancy. [1] **Why Lymphatic Invasion is Correct:** The characteristic appearance is caused by the **invasion of dermal lymphatics** by tumor emboli. This leads to lymphatic obstruction and localized **lymphedema**. [1] As the skin swells, the hair follicles remain tethered to the underlying dermis by suspensory ligaments (ligaments of Cooper). This creates a pitted, dimpled appearance where the follicles are depressed relative to the edematous surrounding skin, mimicking the texture of an orange peel. **Analysis of Incorrect Options:** * **A & B (Intraepithelial/Subepidermal carcinoma):** These terms refer to the location of the cancer cells within the skin layers. While cancer cells are present in the dermis in peau d'orange, the *mechanism* of the skin change is mechanical fluid backup (edema), not the mere presence of cells in the epithelium. * **D (Vascular embolization):** While tumor cells can enter blood vessels (hematogenous spread), this typically leads to distant metastasis (e.g., to bone or lungs) rather than localized cutaneous edema and dimpling. **NEET-PG High-Yield Pearls:** * **Clinical Significance:** Peau d’orange is a hallmark of **Inflammatory Breast Cancer**, which is clinically staged as **T4d** (locally advanced). * **Differential Diagnosis:** It can also be seen in severe mastitis, though the presence of a mass or lack of response to antibiotics points toward malignancy. * **Pathology Link:** Always associate "dermal lymphatic obstruction" [1] with "peau d'orange" and "Cooper’s ligaments" with the "pitting/dimpling" effect. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 453-454.

Question 423: In which one of the following does the host factor show a bimodal incidence curve?

A. Kaposi's sarcoma
B. Osteosarcoma
C. Hodgkin's lymphoma (Correct Answer)
D. Lung cancer

Explanation: **Explanation:** **Hodgkin’s Lymphoma (HL)** is the classic example of a malignancy with a **bimodal age distribution** [2]. In developed countries, the first peak occurs in young adults (typically ages 15–35), while the second peak occurs in the elderly (usually >50 years) [1], [2]. This pattern is particularly characteristic of the **Nodular Sclerosis** subtype (common in the first peak) and the **Mixed Cellularity** subtype (more common in the second peak) [1]. **Analysis of Incorrect Options:** * **Kaposi’s Sarcoma:** While it has different clinical variants (Classic, Endemic, Iatrogenic, and AIDS-associated), it does not follow a bimodal curve. The classic form primarily affects elderly men, while the AIDS-associated form follows the demographics of the HIV epidemic. * **Osteosarcoma:** This also shows a bimodal-like distribution, but it is less "classic" than HL. The primary peak is in adolescents (during the growth spurt), and a smaller secondary peak occurs in the elderly, usually secondary to **Paget’s disease of bone** or prior radiation. However, in standard pathology exams, HL remains the definitive answer for this concept. * **Lung Cancer:** The incidence of lung cancer increases steadily with age and cumulative exposure to carcinogens (like tobacco smoke), showing a linear increase rather than a bimodal curve. **High-Yield NEET-PG Pearls:** * **Reed-Sternberg (RS) Cells:** The hallmark of HL; they are "Owl-eye" appearing binucleated cells that are **CD15+ and CD30+** (except in the Lymphocyte Predominant type, which is CD20+). * **EBV Association:** Strongly linked with the Mixed Cellularity subtype [1]. * **Prognosis:** Lymphocyte Predominant has the best prognosis [3]; Lymphocyte Depleted has the worst. * **B-Symptoms:** Fever, night sweats, and weight loss are significant prognostic indicators in HL [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 616-618. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 614-616. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 618.

Question 424: The Azzopardi effect is seen in which of the following conditions?

A. Squamous cell carcinoma
B. Large cell carcinoma
C. Small cell carcinoma (Correct Answer)
D. Adenocarcinoma lung

Explanation: **Explanation:** The **Azzopardi effect** (also known as the Azzopardi phenomenon) is a characteristic histopathological feature most commonly associated with **Small Cell Carcinoma (SCLC)** of the lung. **Why Small Cell Carcinoma is correct:** Small cell carcinoma is a highly aggressive neuroendocrine tumor characterized by rapid cell turnover and extensive necrosis [1]. As these cells undergo necrosis, their fragile nuclei break down, releasing a significant amount of **DNA**. This DNA leaches out and encrusts the walls of small blood vessels within the tumor, staining them a deep, intense **basophilic (blue/purple)** color on Hematoxylin and Eosin (H&E) stain. This "DNA encrustation" of vessel walls is the hallmark of the Azzopardi effect. **Why other options are incorrect:** * **Squamous cell carcinoma:** Characterized by keratin pearls and intercellular bridges; it does not typically exhibit the massive DNA release required for this effect. * **Adenocarcinoma:** Characterized by gland formation and mucin production; it lacks the high nuclear-to-cytoplasmic ratio and fragility seen in SCLC. * **Large cell carcinoma:** While it can show necrosis, it lacks the specific neuroendocrine-related nuclear fragility and DNA leaching pattern diagnostic of the Azzopardi effect. **High-Yield Clinical Pearls for NEET-PG:** * **Small Cell Carcinoma** is also associated with: * **Kulchitsky cells** (cells of origin). * **Nuclear molding** and "Oat cell" appearance [1]. * **Paraneoplastic syndromes:** SIADH, ACTH production (Cushing’s), and Lambert-Eaton Myasthenic Syndrome [2]. * **Azzopardi effect** can rarely be seen in other high-grade tumors like Merkel cell carcinoma or some lymphomas, but for exam purposes, it is the classic sign for **Small Cell Carcinoma of the lung**. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 725-727.

Question 425: A child is born with a single functional copy of a tumor suppressor gene. At the age of 5 years, the remaining normal allele is lost through mutation. As a result, the ability to control the transition from G1 to the S phase of the cell cycle is lost. Which of the following neoplasms is most likely to arise by means of this mechanism?

A. Retinoblastoma (Correct Answer)
B. Breast carcinoma
C. Adenocarcinoma of colon
D. Cerebral astrocytoma

Explanation: ### Explanation **Correct Option: A. Retinoblastoma** The scenario describes **Knudson’s "Two-Hit" Hypothesis** of oncogenesis. The child was born with a germline mutation (1st hit) and subsequently acquired a somatic mutation (2nd hit) in the remaining allele [1]. The gene involved is the **RB1 gene** (located on chromosome 13q14), which encodes the pRB protein [2]. **Mechanism:** pRB is the "governor" of the cell cycle [1]. In its hypophosphorylated state, it binds to the **E2F transcription factor**, preventing the cell from entering the S phase [3]. When pRB is lost or inactivated, E2F is released, leading to uncontrolled transition from **G1 to S phase** [3]. This mechanism is classic for familial Retinoblastoma, which typically presents in early childhood (often before age 5) [2]. **Why Incorrect Options are Wrong:** * **B. Breast carcinoma:** While BRCA1/2 are tumor suppressors, they are primarily involved in DNA repair, not direct G1-S checkpoint control [1]. Furthermore, sporadic breast cancer is more common in adults. * **C. Adenocarcinoma of colon:** This typically follows the "Adenoma-Carcinoma sequence" involving APC, KRAS, and p53. While APC is a tumor suppressor, the specific G1-S transition loss described is the hallmark of the RB pathway. * **D. Cerebral astrocytoma:** These are often associated with mutations in TP53 or IDH1/2, but they do not classically follow the specific childhood "two-hit" presentation described for the G1-S governor. **High-Yield Clinical Pearls for NEET-PG:** * **RB1 Gene:** First tumor suppressor gene discovered. * **Two-Hit Hypothesis:** Applies to hereditary cancers (e.g., Retinoblastoma, Li-Fraumeni). * **Osteosarcoma:** Children with hereditary retinoblastoma have a significantly increased risk of developing Osteosarcoma later in life. * **Quiescence:** pRB maintains cells in G0/G1; its phosphorylation by **CDK4/6-Cyclin D** complexes is what normally triggers the S-phase [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-302.

Question 426: Which of the following mutations is NOT involved in tobacco-induced squamous cell carcinoma?

A. P53
B. P16 (Correct Answer)
C. P63
D. NOTCH 1

Explanation: **Explanation:** The molecular pathogenesis of Squamous Cell Carcinoma (SCC), particularly in the head, neck, and lungs, differs significantly based on the primary etiological driver: **Tobacco/Alcohol** vs. **Human Papillomavirus (HPV)**. 1. **Why P16 is the correct answer:** In tobacco-induced SCC, the **P16 (INK4a)** gene is typically **inactivated** or downregulated through mutation or methylation [1]. Conversely, **overexpression of P16** is the hallmark biomarker for **HPV-associated SCC**. In HPV-positive cases, the viral E7 oncoprotein degrades the Rb protein; the loss of Rb feedback leads to a compensatory and massive upregulation (overexpression) of P16. Therefore, P16 "positivity" is not a feature of tobacco-induced SCC. 2. **Analysis of Incorrect Options:** * **P53 (TP53):** This is the most common mutation in tobacco-associated SCC [1]. Carcinogens in tobacco (like benzopyrene) cause direct DNA damage leading to P53 mutations [2]. * **P63:** This is a transcription factor essential for squamous epithelial differentiation. It is frequently **amplified** in squamous cell carcinomas (both lung and head/neck) and serves as a diagnostic immunohistochemical marker for squamous lineage. * **NOTCH 1:** Recent genomic studies have identified NOTCH 1 as one of the most frequently mutated genes in head and neck SCC. It acts as a tumor suppressor in squamous epithelia, and its loss of function promotes oncogenesis. **High-Yield Clinical Pearls for NEET-PG:** * **P16 IHC:** Used as a surrogate marker for high-risk HPV infection (e.g., Oropharyngeal SCC). * **Field Cancerization:** Tobacco exposure creates a "field" of mutated cells (often with P53 mutations), explaining why these patients develop multiple primary tumors. * **SCC Marker Triad:** P63, P40, and Cytokeratin 5/6 are the high-yield IHC markers used to confirm squamous cell origin in pathology. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 720-721. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 331-332.

Question 427: Which of the following is a marker for carcinoma of the colon?

A. AFP
B. CA-125
C. CEA (Correct Answer)
D. HCG

Explanation: **Explanation:** **Correct Answer: C. CEA (Carcinoembryonic Antigen)** CEA is an oncofetal antigen—a protein normally produced during fetal development that disappears after birth but reappears in certain adult malignancies. It is the most widely used tumor marker for **Colorectal Carcinoma (CRC)** [2]. * **Clinical Utility:** CEA is **not** used for screening or primary diagnosis due to low sensitivity and specificity (it can be elevated in smokers, cirrhosis, and inflammatory bowel disease). Its primary role is in **monitoring treatment response** and **detecting recurrence** following surgical resection [1]. **Analysis of Incorrect Options:** * **A. AFP (Alpha-Fetoprotein):** An oncofetal antigen used as a marker for **Hepatocellular Carcinoma (HCC)** and non-seminomatous germ cell tumors (specifically **Yolk Sac Tumors**) [2]. * **B. CA-125:** A high-yield marker for **Serous Ovarian Carcinoma**. It is also used to monitor response to therapy in epithelial ovarian cancers. * **D. HCG (Human Chorionic Gonadotropin):** Elevated in pregnancy, but as a tumor marker, it signifies **Choriocarcinoma** or hydatidiform moles. It is also elevated in some testicular germ cell tumors. **High-Yield Clinical Pearls for NEET-PG:** * **Most specific marker for CRC:** While CEA is most common, CA 19-9 can also be elevated (though primarily associated with Pancreatic Cancer). * **Prognosis:** Persistently high preoperative CEA levels correlate with a poor prognosis and higher likelihood of metastasis. * **Other GI Markers:** CA 19-9 (Pancreas/Cholangiocarcinoma), AFP (Liver), and Gastrin (Zollinger-Ellison Syndrome). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 214-215. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 344-346.

Question 428: What is the most definite feature of a malignant tumour?

A. Haemorrhage
B. Increased mitoses
C. Metastasis (Correct Answer)
D. Necrosis

Explanation: **Explanation:** The hallmark of malignancy is the ability of a tumor to spread to distant sites, a process known as **metastasis** [4, 5]. It is considered the most definitive and unequivocal feature of malignancy because it confirms that the tumor has breached the basement membrane, entered the circulation (blood or lymphatics), and established independent growth in a non-contiguous organ [5]. Except for certain primary CNS tumors and Basal Cell Carcinomas, almost all malignant tumors have the potential to metastasize [2, 4]. **Analysis of Options:** * **Metastasis (Correct):** It is the "gold standard" for diagnosing malignancy. While **Invasiveness** is the second most reliable feature [2], metastasis is the ultimate proof of a malignant process. * **Increased Mitoses (Incorrect):** While malignant cells divide rapidly, an increased mitotic rate is also seen in physiological processes (e.g., regenerating liver, endometrium during the menstrual cycle) and benign tumors. Furthermore, the *quality* of mitosis (atypical/tripolar spindles) is more suggestive of malignancy than the *quantity*. * **Haemorrhage and Necrosis (Incorrect):** These occur when a rapidly growing tumor outstrips its blood supply [1]. While common in large malignant masses, they are non-specific and can occur in benign tumors (e.g., degenerating uterine leiomyoma) or inflammatory conditions. **High-Yield Clinical Pearls for NEET-PG:** * **Exceptions:** Basal Cell Carcinoma (BCC) and Gliomas are malignant but rarely metastasize; they are primarily "locally invasive" [2, 4]. * **Pathways of Spread:** Carcinomas typically spread via **lymphatics** (sentinel node is the first node), while Sarcomas prefer **haematogenous** spread [5]. * **Renal Cell Carcinoma (RCC) and Hepatocellular Carcinoma (HCC)** are notable exceptions—they are carcinomas that frequently spread via the venous route [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 207-208. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 206-207. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 282. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 280-282. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 233-234.

Question 429: A 51-year-old male with a 20-year history of tobacco chewing presents with a slowly enlarging, white, irregular mass on the floor of his mouth, measuring 1.3 cm. Biopsies of this lesion are most likely to reveal which malignancy?

A. Acinic cell carcinoma
B. Adenocarcinoma
C. Basal cell carcinoma
D. Squamous cell carcinoma (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Squamous cell carcinoma (SCC)** The clinical presentation of a chronic tobacco user with a white, irregular mass (leukoplakia) on the floor of the mouth is a classic description of **Oral Squamous Cell Carcinoma**. [1] * **Pathophysiology:** Chronic exposure to carcinogens in tobacco (such as nitrosamines) leads to a field of cancerization. [1] This process involves progressive genetic mutations (e.g., p53, p16) in the squamous epithelium, transitioning from dysplasia to carcinoma in situ and finally to invasive SCC. [3] * **Clinical Correlation:** The floor of the mouth and the lateral borders of the tongue are the most common sites for oral SCC. [1] A persistent "white patch" (leukoplakia) or "red patch" (erythroplakia) that becomes indurated or ulcerated is highly suspicious for malignancy. [2] **Why Other Options are Incorrect:** * **A & B (Acinic cell carcinoma / Adenocarcinoma):** These are malignancies of the salivary glands. While they can occur in minor salivary glands in the oral cavity, they typically present as smooth, submucosal swellings rather than irregular surface masses associated with tobacco-induced epithelial changes. * **C (Basal cell carcinoma):** BCC is primarily a skin cancer caused by UV radiation. It almost never occurs within the oral cavity (mucous membranes). **NEET-PG High-Yield Pearls:** * **Risk Factors:** Tobacco (chewing/smoking), alcohol, and HPV-16/18 (specifically for oropharyngeal SCC). [1] * **Precursor Lesions:** Erythroplakia carries a much higher risk of malignant transformation (approx. 50%) compared to leukoplakia (approx. 1–5%). [2] * **Histology:** Look for "keratin pearls" and "intercellular bridges" (desmosomes) on biopsy. * **Staging:** The most important prognostic factor for oral SCC is the presence of cervical lymph node metastasis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 738-739. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 344-345. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 739-741.

Question 430: A metastatic carcinoma in the brain of an adult most often originates from a primary tumor in which of the following locations?

A. Stomach
B. Ovary
C. Oral cavity
D. Lung (Correct Answer)

Explanation: **Explanation:** **1. Why Lung is Correct:** Metastatic tumors are the most common cause of neoplasia in the central nervous system (CNS) in adults, outnumbering primary brain tumors [1]. The **lung** is the most frequent primary site, accounting for approximately **40-50%** of all brain metastases [1], [2]. This occurs via hematogenous spread through the arterial circulation. Both Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC), particularly adenocarcinoma, have a high propensity for early brain involvement. **2. Why Other Options are Incorrect:** * **Stomach:** While gastric cancer can metastasize hematogenously, it typically spreads to the liver (via the portal system) or the peritoneum (Krukenberg tumor). Brain metastasis from the GI tract is relatively rare [1]. * **Ovary:** Ovarian cancer primarily spreads via local seeding across the peritoneal cavity. Distant hematogenous spread to the brain is an uncommon and late-stage event. * **Oral Cavity:** Squamous cell carcinomas of the oral cavity tend to spread via the lymphatic system to local cervical lymph nodes. Distant metastasis to the brain is rare compared to lung, breast, or melanoma. **3. High-Yield Facts for NEET-PG:** * **Frequency of Brain Metastasis (Descending Order):** Lung > Breast > Melanoma > Renal Cell Carcinoma > Colon [1]. * **Melanoma:** Has the highest *percentage* of cases that spread to the brain (high tropism), but because lung cancer is more common overall, it remains the #1 source [1]. * **Presentation:** Metastatic lesions are typically **multiple**, well-circumscribed, and located at the **gray-white matter junction** (where caliber of vessels narrows, trapping tumor emboli). * **Pediatric Contrast:** In children, primary brain tumors (e.g., Medulloblastoma, Astrocytoma) are more common than metastases. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1317-1318. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-725.

Practice by Chapter

Nomenclature and Classification of Tumors

Practice Questions

Characteristics of Benign and Malignant Neoplasms

Practice Questions

Molecular Basis of Cancer

Practice Questions

Carcinogenesis and Carcinogens

Practice Questions

Tumor Progression and Metastasis

Practice Questions

Tumor Markers

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Genetic Basis of Cancer

Practice Questions

Tumor Immunity

Practice Questions

Cancer Epidemiology and Prevention

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?